HEMARATE FA Iron / Vitamin B Complex / Folic Acid 60mg / 600mg / 20mg / 25mg Tablet 100's
NONRXDRUG-DR-XY308020
Discreet Packaging
FDA-registered Products
FDA-licensed Pharmacies
Indications/Uses
For the prevention and treatment of iron deficiency anemia, folate deficiency and for the lowering of plasma homocysteine.
Dosage/Direction for Use
Orally, one tablet daily as soon as pregnancy is detected.
Or, as directed by a doctor.
Missed Dose: If the patient misses a dose, just take the next dose and the subsequent doses at the usual recommended schedule, i.e., once a day.
Do not double the dose unless recommended by a doctor.
Or, as directed by a doctor.
Missed Dose: If the patient misses a dose, just take the next dose and the subsequent doses at the usual recommended schedule, i.e., once a day.
Do not double the dose unless recommended by a doctor.
Overdosage
Iron: Acute iron overdosage (e.g., intake of ≥1,500 mg elemental iron for a 50 kg adult) can be divided into four stages: Stage I: Occurs up to six hours after ingestion, the principal symptoms are vomiting and diarrhea. Other symptoms include hypotension, tachycardia (rapid heartbeat) and central nervous system depression ranging from lethargy (sleepiness) to coma (state of unconsciousness).
Stage II: May occur 6 to 24 hours after ingestion and is characterized by a temporary remission or signs of overdosage are decreased.
Stage III: GI symptoms recur accompanied by shock, metabolic acidosis (increased acid in the blood), coma, hepatic necrosis (death of liver tissue), jaundice (yellowish color of the skin, eyes and other tissues), hypoglycemia (low blood sugar), kidney failure, and pulmonary edema (fluid in the lungs).
Stage IV: Occurs several weeks after ingestion and is characterized by GI obstruction (blockage) and liver damage.
Vitamin B6: Long term administration (i.e., 2 months or longer) of large (megadose) dosages (e.g., 2 g or more daily) of pyridoxine can cause sensory neuropathy or neuronopathy syndromes.
Other side effects reported with megadoses of pyridoxine include peripheral neuropathy, unsteady gait (manner of walking), loss of limb reflexes/numbness and tingling in feet and hands, hyperesthesia (increased physical sensitivity), muscle weakness, impaired or absent tendon reflexes; bone pain, headache, dizziness, sleepiness, nausea, upset stomach, breast tenderness, photosensitivity on sun exposure, and exacerbation of acne.
If the patient has taken more than the recommended dosage, consult a doctor or contact a poison control center immediately.
Stage II: May occur 6 to 24 hours after ingestion and is characterized by a temporary remission or signs of overdosage are decreased.
Stage III: GI symptoms recur accompanied by shock, metabolic acidosis (increased acid in the blood), coma, hepatic necrosis (death of liver tissue), jaundice (yellowish color of the skin, eyes and other tissues), hypoglycemia (low blood sugar), kidney failure, and pulmonary edema (fluid in the lungs).
Stage IV: Occurs several weeks after ingestion and is characterized by GI obstruction (blockage) and liver damage.
Vitamin B6: Long term administration (i.e., 2 months or longer) of large (megadose) dosages (e.g., 2 g or more daily) of pyridoxine can cause sensory neuropathy or neuronopathy syndromes.
Other side effects reported with megadoses of pyridoxine include peripheral neuropathy, unsteady gait (manner of walking), loss of limb reflexes/numbness and tingling in feet and hands, hyperesthesia (increased physical sensitivity), muscle weakness, impaired or absent tendon reflexes; bone pain, headache, dizziness, sleepiness, nausea, upset stomach, breast tenderness, photosensitivity on sun exposure, and exacerbation of acne.
If the patient has taken more than the recommended dosage, consult a doctor or contact a poison control center immediately.
Administration
Should be taken on an empty stomach: Preferably taken between meals. May be taken w/ meals to reduce GI discomfort.
Contraindications
If the patient is allergic to any ingredient in the product.
Iron supplement should be avoided in conditions associated with iron overload (e.g., hemochromatosis, hemosiderosis, thalassemia).
Iron supplement should be avoided in conditions associated with iron overload (e.g., hemochromatosis, hemosiderosis, thalassemia).
Special Precautions
Iron supplement should be used with extreme caution in those with chronic liver failure, alcoholic cirrhosis, chronic alcoholism, and pancreatic insufficiency.
Iron should be used cautiously in those with a history of gastritis, peptic ulcer, and GI bleeding.
Individuals with an active or suspected infection should generally avoid iron supplements.
A moderate increase in iron stores has been associated with an increased risk of ischemic heart disease and cancer.
Do not take more than the recommended dose. If the patient is taking other supplements, read the label, since those supplements may contain the same ingredients as this product.
Consult a doctor: If any undesirable effect occurs.
Iron should be used cautiously in those with a history of gastritis, peptic ulcer, and GI bleeding.
Individuals with an active or suspected infection should generally avoid iron supplements.
A moderate increase in iron stores has been associated with an increased risk of ischemic heart disease and cancer.
Do not take more than the recommended dose. If the patient is taking other supplements, read the label, since those supplements may contain the same ingredients as this product.
Consult a doctor: If any undesirable effect occurs.
Adverse Reactions
The amount of nutrients in this product is relatively nontoxic and is usually well tolerated. However, undesirable effects may occur, particularly when the nutrients are used at high doses (e.g., concomitant use of other multivitamin-mineral supplements), see also Overdosage.
Iron: The most common undesirable effects of iron are gastrointestinal (GI) problems, including nausea, vomiting, bloating, abdominal discomfort/epigastric pain, black stools, diarrhea, constipation and anorexia.
Nervous system disorders: Metallic taste.
Gastrointestinal disorders: flatulence, gastrointestinal irritation, heartburn, stomach discomfort.
Injury, poisoning and procedural complications: Long-term administration of large amounts of iron may cause hemosiderosis clinically resembling hemochromatosis, which is a genetic condition characterized by excessive iron absorption, excess tissue iron stores, and potential tissue injury.
Vitamin B6: Although vitamin B6 is generally considered to be relatively nontoxic, adverse neurologic effects have been reported following chronic administration of large pyridoxine dosages, e.g., more than 200 mg daily.
Psychiatric disorders: Sleepiness.
Nervous system disorders: Headache, paresthesia (tingling, prickling, or burning sensation).
Gastrointestinal disorders: Nausea.
Investigations: Decreased serum folic acid concentrations, increased serum aspartate aminotransferase (AST, a liver enzyme).
Iron: The most common undesirable effects of iron are gastrointestinal (GI) problems, including nausea, vomiting, bloating, abdominal discomfort/epigastric pain, black stools, diarrhea, constipation and anorexia.
Nervous system disorders: Metallic taste.
Gastrointestinal disorders: flatulence, gastrointestinal irritation, heartburn, stomach discomfort.
Injury, poisoning and procedural complications: Long-term administration of large amounts of iron may cause hemosiderosis clinically resembling hemochromatosis, which is a genetic condition characterized by excessive iron absorption, excess tissue iron stores, and potential tissue injury.
Vitamin B6: Although vitamin B6 is generally considered to be relatively nontoxic, adverse neurologic effects have been reported following chronic administration of large pyridoxine dosages, e.g., more than 200 mg daily.
Psychiatric disorders: Sleepiness.
Nervous system disorders: Headache, paresthesia (tingling, prickling, or burning sensation).
Gastrointestinal disorders: Nausea.
Investigations: Decreased serum folic acid concentrations, increased serum aspartate aminotransferase (AST, a liver enzyme).
Drug Interactions
Iron: Cefdinir; bisphosphonates; carbidopa/levodopa; entacapone; fluoroquinolones; levodopa; levothyroxine; methyldopa; mycophenolate mofetil; penicillamine; and tetracyclines: Iron may reduce the absorption of these drugs.
Tell the doctor about other medicines the patient is taking including supplements and herbal products.
Tell the doctor about other medicines the patient is taking including supplements and herbal products.
Storage
Store at temperatures not exceeding 30°C.
Protect from light.
Protect from light.
MedsGo Class
Vitamins & Minerals (Pre & Post Natal) / Antianemics
Features
Brand
HEMARATE FA
Full Details
Dosage Strength
60mg / 600mg / 20mg / 25mg
Drug Ingredients
- Iron
- Vit. B9 (Folic Acid)
- Vitamin B Complex
Drug Packaging
Tablet 100's
Generic Name
Iron / Vit. B9 (Folic Acid) / Vitamin B Complex
Dosage Form
Tablet
Registration Number
DR-XY308020
Drug Classification
Over-The-Counter (OTC)
View all variations as list
| CODE | Dosage Strength | Drug Packaging | Availability | Price | ||
|---|---|---|---|---|---|---|
|
NONRXDRUG-DR-XY308020-1pc
|
In stock
|
₱2640 |
Please sign in so that we can notify you about a reply